CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
59.73
+0.91 (1.55%)
At close: Aug 15, 2025, 4:00 PM
59.92
+0.19 (0.32%)
After-hours: Aug 15, 2025, 7:59 PM EDT
CRISPR Therapeutics AG (CRSP) Operating Expense Breakdown
History
| Date | Research and Development | Collaboration | General and Administrative |
|---|---|---|---|
| Jun 30, 2025 | 306.69M | 165.95M | 73.76M |
| Mar 31, 2025 | 316.96M | 167.76M | 74.32M |
| Dec 31, 2024 | 320.65M | 130.25M | 72.98M |
| Sep 30, 2024 | 333.64M | 142.52M | 71.33M |
| Jun 30, 2024 | 342.18M | 135.02M | 72.20M |
| Mar 31, 2024 | 363.57M | 130.25M | 71.76M |
| Dec 31, 2023 | 387.33M | 117.07M | 76.16M |
| Sep 30, 2023 | 395.74M | 132.51M | 80.85M |
| Jun 30, 2023 | 421.67M | 121.80M | 89.56M |
| Mar 31, 2023 | 443.34M | 110.25M | 96.80M |
| Dec 31, 2022 | 461.65M | 135.25M | 102.46M |
| Sep 30, 2022 | 461.19M | 118.86M | 104.97M |
| Jun 30, 2022 | 428.06M | 111.88M | 101.68M |
| Mar 31, 2022 | 387.17M | 101.18M | 104.21M |
| Dec 31, 2021 | 339.55M | - | 100.71M |
| Sep 30, 2021 | 318.82M | - | 102.80M |
| Jun 30, 2021 | 306.33M | - | 100.63M |
| Mar 31, 2021 | 283.37M | - | 93.18M |
| Dec 31, 2020 | 266.95M | - | 88.21M |
| Sep 30, 2020 | 233.34M | - | 79.71M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.